A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors (Q46139159)
Jump to navigation
Jump to search
scientific article published on 21 November 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors |
scientific article published on 21 November 2016 |
Statements
A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors (English)
1 reference
Desamparados Roda
Teresa Macarulla
Rafael Morales-Barrera
Juan Manuel Sanchis-GarcĂa
Luna Musib
Nageshwar Budha
Jin Zhu
Michelle Nannini
Wai Y Chan
Raymond D Meng
Kui Lin
Yibing Yan
Premal Patel
José Baselga
21 November 2016
1 reference